Neupath Health Stock Today

NPTH Stock  CAD 0.21  0.01  4.55%   

Performance

8 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 20

 
High
 
Low
Low
NeuPath Health is selling for under 0.21 as of the 18th of January 2025; that is 4.55 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.2. NeuPath Health has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.. The company has 56.4 M outstanding shares of which 158 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions. More on NeuPath Health

Moving together with NeuPath Stock

  0.61MNT Royal Canadian MintPairCorr

Moving against NeuPath Stock

  0.56HIVE HIVE Blockchain TechPairCorr
  0.53AOT Ascot ResourcesPairCorr
  0.33CYB CymbriaPairCorr

NeuPath Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NeuPath Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NeuPath Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Management, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
NeuPath Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to NeuPath Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
NeuPath Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NeuPath Health's financial leverage. It provides some insight into what part of NeuPath Health's total assets is financed by creditors.
Liquidity
NeuPath Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. NeuPath Health has accumulated 195 K in total debt with debt to equity ratio (D/E) of 0.67, which is about average as compared to similar companies. NeuPath Health has a current ratio of 1.24, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist NeuPath Health until it has trouble settling it off, either with new capital or with free cash flow. So, NeuPath Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NeuPath Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NeuPath to invest in growth at high rates of return. When we think about NeuPath Health's use of debt, we should always consider it together with cash and equity.

Net Income

(129,202)
NeuPath Health (NPTH) is traded on TSX Venture Exchange in Canada and employs 156 people. NeuPath Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeuPath Health's market, we take the total number of its shares issued and multiply it by NeuPath Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NeuPath Health operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 56.4 M outstanding shares of which 158 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions. NeuPath Health has accumulated about 7.48 M in cash with 3.03 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check NeuPath Health Probability Of Bankruptcy
Ownership Allocation
NeuPath Health maintains a total of 56.4 Million outstanding shares. Roughly 74.78 % of NeuPath Health outstanding shares are held by general public with 0.98 pct. owned by insiders and only 24.24 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NeuPath Ownership Details

NeuPath Health Risk Profiles

Although NeuPath Health's alpha and beta are two of the key measurements used to evaluate NeuPath Health's performance over the market, the standard measures of volatility play an important role as well.

NeuPath Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in NeuPath Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.